BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Early FDA wins: Corcept’s Lifyorli, Denali’s Avlayah
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
ERT therapy enhances clinical response to tacrine in Alzheimer's patients
July 26, 1996
CP-122638: Pfizer's potential treatment for non-migraine emesis
July 26, 1996
5-HT3/NK1 antagonist combination effective in emesis treatment and prevention
July 26, 1996
Vanderbilt University describes ligands for 5-HT3 receptors
July 26, 1996
MBP peptide analogues described as multiple sclerosis treatment
July 26, 1996
Yeda claims protein as potential autoimmune disease treatment
July 26, 1996
Chinoin describes new selegiline formulation
July 26, 1996
Raloxifene indicated for excess NPY associated disorders
July 26, 1996
Pierre Fabre reports 5-HT1A agonists
July 26, 1996
Duloxetine claimed for new indication
July 26, 1996
Previous
1
2
…
2765
2766
2767
2768
2769
2770
2771
2772
2773
…
2796
2797
Next
RSS